|
1
|
Roger VL: Epidemiology of heart failure.
Circ Res. 113:646–659. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Roger VL, Weston SA, Redfield MM,
Hellermann-Homan JP, Killian J, Yawn BP and Jacobsen SJ: Trends in
heart failure incidence and survival in a community-based
population. JAMA. 292:344–350. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Hoydal MA, Kirkeby-Garstad I, Karevold A,
Wiseth R, Haaverstad R, Wahba A, Stølen TL, Contu R, Condorelli G,
Ellingsen Ø, et al: Human cardiomyocyte calcium handling and
transverse tubules in mid-stage of post-myocardial-infarction heart
failure. ESC Heart Fail. 5:332–342. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
McMurray JJ, Adamopoulos S, Anker SD,
Auricchio A, Böhm M, Dickstein K, Falk V, Filippatos G, Fonseca C,
Gomez-Sanchez MA, et al: ESC Guidelines for the diagnosis and
treatment of acute and chronic heart failure 2012: The Task Force
for the Diagnosis and Treatment of Acute and Chronic Heart Failure
2012 of the European Society of Cardiology. Developed in
collaboration with the Heart Failure Association (HFA) of the ESC.
Eur Heart J. 33:1787–1847. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Hellermann JP, Jacobsen SJ, Gersh BJ,
Rodeheffer RJ, Reeder GS and Roger VL: Heart failure after
myocardial infarction: A review. Am J Med. 113:324–330. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Borghi C, Bacchelli S, Degli Esposti D and
Ambrosioni E; Survival of Myocardial Infarction Long-Term
Evaluation Study, : Effects of early angiotensin-converting enzyme
inhibition in patients with non-ST-elevation acute anterior
myocardial infarction. Am Heart J. 152:470–477. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
O'Connor CM, Hathaway WR, Bates ER,
Leimberger JD, Sigmon KN, Kereiakes DJ, George BS, Samaha JK,
Abbottsmith CW, Candela RJ, et al: Clinical characteristics and
long-term outcome of patients in whom congestive heart failure
develops after thrombolytic therapy for acute myocardial
infarction: Development of a predictive model. Am Heart J.
133:663–673. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
de Lemos JA, Morrow DA, Bentley JH, Omland
T, Sabatine MS, McCabe CH, Hall C, Cannon CP and Braunwald E: The
prognostic value of B-type natriuretic peptide in patients with
acute coronary syndromes. N Engl J Med. 345:1014–1021. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Haeck JD, Verouden NJ, Kuijt WJ, Koch KT,
Van Straalen JP, Fischer J, Groenink M, Bilodeau L, Tijssen JG,
Krucoff MW and De Winter RJ: Comparison of usefulness of N-terminal
pro-brain natriuretic peptide as an independent predictor of
cardiac function among admission cardiac serum biomarkers in
patients with anterior wall versus nonanterior wall ST-segment
elevation myocardial infarction undergoing primary percutaneous
coronary intervention. Am J Cardiol. 105:1065–1069. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Tousoulis D, Kampoli AM, Stefanadi E,
Antoniades C, Siasos G, Papavassiliou AG and Stefanadis C: New
biochemical markers in acute coronary syndromes. Curr Med Chem.
15:1288–1296. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Moe KT and Wong P: Current trends in
diagnostic biomarkers of acute coronary syndrome. Ann Acad Med
Singapore. 39:210–215. 2010.PubMed/NCBI
|
|
12
|
Hall PA, Reis-Filho JS, Tomlinson IP and
Poulsom R: An introduction to genes, genomes and disease. J Pathol.
220:109–113. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Heidecker B and Hare JM: The use of
transcriptomic biomarkers for personalized medicine. Heart Fail
Rev. 12:1–11. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Gurwitz D: Expression profiling: A
cost-effective biomarker discovery tool for the personal genome
era. Genome Med. 5:412013. View
Article : Google Scholar : PubMed/NCBI
|
|
15
|
Maciejak A, Kiliszek M, Michalak M, Tulacz
D, Opolski G, Matlak K, Dobrzycki S, Segiet A, Gora M and Burzynska
B: Gene expression profiling reveals potential prognostic
biomarkers associated with the progression of heart failure. Genome
Med. 7:262015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Gautier L, Cope L, Bolstad BM and Irizarry
RA: Affy-analysis of Affymetrix GeneChip data at the probe level.
Bioinformatics. 20:307–315. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Ritchie ME, Phipson B, Wu D, Hu Y, Law CW,
Shi W and Smyth GK: limma powers differential expression analyses
for RNA-sequencing and microarray studies. Nucleic Acids Res.
43:e472015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Sturn A, Quackenbush J and Trajanoski Z:
Genesis: Cluster analysis of microarray data. Bioinformatics.
18:207–208. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Dennis G Jr, Sherman BT, Hosack DA, Yang
J, Gao W, Lane HC and Lempicki RA: DAVID: Database for Annotation,
Visualization, and Integrated Discovery. Genome Biol. 4:P32003.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Stelzl U, Worm U, Lalowski M, Haenig C,
Brembeck FH, Goehler H, Stroedicke M, Zenkner M, Schoenherr A,
Koeppen S, et al: A human protein-protein interaction network: A
resource for annotating the proteome. Cell. 122:957–968. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Franceschini A, Szklarczyk D, Frankild S,
Kuhn M, Simonovic M, Roth A, Lin J, Minguez P, Bork P, von Mering C
and Jensen LJ: STRING v9.1: Protein-protein interaction networks,
with increased coverage and integration. Nucleic Acids Res.
41:D808–D815. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Shannon P, Markiel A, Ozier O, Baliga NS,
Wang JT, Ramage D, Amin N, Schwikowski B and Ideker T: Cytoscape: A
software environment for integrated models of biomolecular
interaction networks. Genome Res. 13:2498–2504. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Bader GD and Hogue CW: An automated method
for finding molecular complexes in large protein interaction
networks. BMC Bioinformatics. 4:22003. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Maere S, Heymans K and Kuiper M: BiNGO: A
Cytoscape plugin to assess overrepresentation of gene ontology
categories in biological networks. Bioinformatics. 21:3448–3449.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Li SW, Lin K, Ma P, Zhang ZL, Zhou YD, Lu
SY, Zhou X and Liu SM: FADS gene polymorphisms confer the risk of
coronary artery disease in a Chinese Han population through the
altered desaturase activities: Based on high-resolution melting
analysis. PLoS One. 8:e558692013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Rupp H, Rupp TP, Alter P and Maisch B: N-3
polyunsaturated fatty acids and statins in heart failure. Lancet.
373:378–380. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Rupp H, Rupp TP, Alter P and Maisch B:
Inverse shift in serum polyunsaturated and monounsaturated fatty
acids is associated with adverse dilatation of the heart. Heart.
96:595–598. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Rupp H, Rupp TP, Alter P and Maisch B:
Mechanisms involved in the differential reduction of omega-3 and
omega-6 highly unsaturated fatty acids by structural heart disease
resulting in ‘HUFA deficiency’. Can J Physiol Pharmacol. 90:55–73.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Alter P, Gluck T, Figiel JH, Koczulla AR,
Vogelmeier CF and Rupp H: From heart failure to highly unsaturated
fatty acid deficiency and vice versa: Bidirectional heart and liver
interactions. Can J Cardiol. 32:217–225. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Anderson JS, Nettleton JA, Hundley WG,
Tsai MY, Steffen LM, Lemaitre RN, Siscovick D, Lima J, Prince MR
and Herrington D: Associations of plasma phospholipid omega-6 and
omega-3 polyunsaturated Fatty Acid levels and MRI measures of
cardiovascular structure and function: The multiethnic study of
atherosclerosis. J Nutr Metab. 2011:3151342011. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Hamano S, Ohira M, Isogai E, Nakada K and
Nakagawara A: Identification of novel human neuronal leucine-rich
repeat (hNLRR) family genes and inverse association of expression
of Nbla10449/hNLRR-1 and Nbla10677/hNLRR-3 with the prognosis of
primary neuroblastomas. Int J Oncol. 24:1457–1466. 2004.PubMed/NCBI
|
|
32
|
Fukamachi K, Matsuoka Y, Ohno H, Hamaguchi
T and Tsuda H: Neuronal leucine-rich repeat protein-3 amplifies
MAPK activation by epidermal growth factor through a
carboxyl-terminal region containing endocytosis motifs. J Biol
Chem. 277:43549–43552. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Yokota T and Wang Y: p38 MAP kinases in
the heart. Gene. 575:369–376. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Zhang Q, Lu L, Liang T, Liu M, Wang ZL and
Zhang PY: MAPK pathway regulated the cardiomyocyte apoptosis in
mice with post-infarction heart failure. Bratisl Lek Listy.
118:339–346. 2017.PubMed/NCBI
|
|
35
|
Fei AH, Wang FC, Wu ZB and Pan SM:
Phosphocreatine attenuates angiotensin II-induced cardiac fibrosis
in rat cardiomyocytes through modulation of MAPK and NF-κB pathway.
Eur Rev Med Pharmacol Sci. 20:2726–2733. 2016.PubMed/NCBI
|
|
36
|
Deng HK, Unutmaz D, KewalRamani VN and
Littman DR: Expression cloning of new receptors used by simian and
human immunodeficiency viruses. Nature. 388:296–300. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Nguyen LP, Pan J, Dinh TT, Hadeiba H,
O'Hara E III, Ebtikar A, Hertweck A, Gökmen MR, Lord GM, Jenner RG,
et al: Role and species-specific expression of colon T cell homing
receptor GPR15 in colitis. Nat Immunol. 16:207–213. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Koks G, Uudelepp ML, Limbach M, Peterson
P, Reimann E and Koks S: Smoking-induced expression of the GPR15
gene indicates its potential role in chronic inflammatory
pathologies. Am J Pathol. 185:2898–2906. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Pan B, Wang X, Nishioka C, Honda G,
Yokoyama A, Zeng L, Xu K and Ikezoe T: G-protein coupled receptor
15 mediates angiogenesis and cytoprotective function of
thrombomodulin. Sci Rep. 7:6922017. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Dzeja P and Terzic A: Adenylate kinase and
AMP signaling networks: Metabolic monitoring, signal communication
and body energy sensing. Int J Mol Sci. 10:1729–1772. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Hardie DG and Hawley SA: AMP-activated
protein kinase: The energy charge hypothesis revisited. Bioessays.
23:1112–1119. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Lai Y, Hu X, Chen G, Wang X and Zhu B:
Down-regulation of adenylate kinase 5 in temporal lobe epilepsy
patients and rat model. J Neurol Sci. 366:20–26. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Huang S and Frangogiannis NG:
Anti-inflammatory therapies in myocardial infarction: Failures,
hopes and challenges. Br J Pharmacol. 175:1377–1400. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Fang L, Moore XL, Dart AM and Wang LM:
Systemic inflammatory response following acute myocardial
infarction. J Geriatr Cardiol. 12:305–312. 2015.PubMed/NCBI
|
|
45
|
Nakayama H and Otsu K: Translation of
hemodynamic stress to sterile inflammation in the heart. Trends
Endocrinol Metab. 24:546–553. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Yndestad A, Damas JK, Oie E, Ueland T,
Gullestad L and Aukrust P: Systemic inflammation in heart
failure-the whys and wherefores. Heart Fail Rev. 11:83–92. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Levine B, Kalman J, Mayer L, Fillit HM and
Packer M: Elevated circulating levels of tumor necrosis factor in
severe chronic heart failure. N Engl J Med. 323:236–241. 1990.
View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Pye M, Rae AP and Cobbe SM: Study of serum
C-reactive protein concentration in cardiac failure. Br Heart J.
63:228–230. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Testa M, Yeh M, Lee P, Fanelli R,
Loperfido F, Berman JW and LeJemtel TH: Circulating levels of
cytokines and their endogenous modulators in patients with mild to
severe congestive heart failure due to coronary artery disease or
hypertension. J Am Coll Cardiol. 28:964–971. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Abbate A, Salloum FN, Vecile E, Das A,
Hoke NN, Straino S, Biondi-Zoccai GG, Houser JE, Qureshi IZ, Ownby
ED, et al: Anakinra, a recombinant human interleukin-1 receptor
antagonist, inhibits apoptosis in experimental acute myocardial
infarction. Circulation. 117:2670–2683. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Toldo S, Mezzaroma E, Van Tassell BW,
Farkas D, Marchetti C, Voelkel NF and Abbate A: Interleukin-1β
blockade improves cardiac remodelling after myocardial infarction
without interrupting the inflammasome in the mouse. Exp Physiol.
98:734–745. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Deswal A, Bozkurt B, Seta Y,
Parilti-Eiswirth S, Hayes FA, Blosch C and Mann DL: Safety and
efficacy of a soluble P75 tumor necrosis factor receptor (Enbrel,
etanercept) in patients with advanced heart failure. Circulation.
99:3224–3226. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Frieler RA and Mortensen RM: Immune cell
and other noncardiomyocyte regulation of cardiac hypertrophy and
remodeling. Circulation. 131:1019–1030. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Nahrendorf M and Swirski FK: Innate immune
cells in ischaemic heart disease: Does myocardial infarction beget
myocardial infarction? Eur Heart J. 37:868–872. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Frangogiannis NG: The immune system and
cardiac repair. Pharmacol Res. 58:88–111. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Frangogiannis NG: The immune system and
the remodeling infarcted heart: Cell biological insights and
therapeutic opportunities. J Cardiovasc Pharmacol. 63:185–195.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Gullestad L, Aass H, Fjeld JG, Wikeby L,
Andreassen AK, Ihlen H, Simonsen S, Kjekshus J, Nitter-Hauge S,
Ueland T, et al: Immunomodulating therapy with intravenous
immunoglobulin in patients with chronic heart failure. Circulation.
103:220–225. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Jiang DS, Li L, Huang L, Gong J, Xia H,
Liu X, Wan N, Wei X, Zhu X, Chen Y, et al: Interferon regulatory
factor 1 is required for cardiac remodeling in response to pressure
overload. Hypertension. 64:77–86. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Jiang DS, Wei X, Zhang XF, Liu Y, Zhang Y,
Chen K, Gao L, Zhou H, Zhu XH, Liu PP, et al: IRF8 suppresses
pathological cardiac remodelling by inhibiting calcineurin
signalling. Nat Commun. 5:33032014. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Yang Y, Lv J, Jiang S, Ma Z, Wang D, Hu W,
Deng C, Fan C, Di S, Sun Y and Yi W: The emerging role of Toll-like
receptor 4 in myocardial inflammation. Cell Death Dis. 7:e22342016.
View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Liu L, Wang Y, Cao ZY, Wang MM, Liu XM,
Gao T, Hu QK, Yuan WJ and Lin L: Up-regulated TLR4 in
cardiomyocytes exacerbates heart failure after long-term myocardial
infarction. J Cell Mol Med. 19:2728–2740. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Mann DL, Topkara VK, Evans S and Barger
PM: Innate immunity in the adult mammalian heart: For whom the cell
tolls. Trans Am Clin Climatol Assoc. 121:34–51. 2010.PubMed/NCBI
|
|
63
|
de Winter RJ, Manten A, de Jong YP, Adams
R, van Deventer SJ and Lie KI: Interleukin 8 released after acute
myocardial infarction is mainly bound to erythrocytes. Heart.
78:598–602. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Nymo SH, Hulthe J, Ueland T, McMurray J,
Wikstrand J, Askevold ET, Yndestad A, Gullestad L and Aukrust P:
Inflammatory cytokines in chronic heart failure: Interleukin-8 is
associated with adverse outcome. Results from CORONA. Eur J Heart
Fail. 16:68–75. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Husebye T, Eritsland J, Arnesen H,
Bjørnerheim R, Mangschau A, Seljeflot I and Andersen GØ:
Association of interleukin 8 and myocardial recovery in patients
with ST-elevation myocardial infarction complicated by acute heart
failure. PLoS One. 9:e1123592014. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Saxena A, Chen W, Su Y, Rai V, Uche OU, Li
N and Frangogiannis NG: IL-1 induces proinflammatory leukocyte
infiltration and regulates fibroblast phenotype in the infarcted
myocardium. J Immunol. 191:4838–4848. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Orn S, Ueland T, Manhenke C, Sandanger Ø,
Godang K, Yndestad A, Mollnes TE, Dickstein K and Aukrust P:
Increased interleukin-1β levels are associated with left
ventricular hypertrophy and remodelling following acute ST segment
elevation myocardial infarction treated by primary percutaneous
coronary intervention. J Intern Med. 272:267–276. 2012. View Article : Google Scholar : PubMed/NCBI
|
